GW researchers will participate in a four-site, Phase I clinical trial, funded by the Bill & Melinda Gates Foundation and in collaboration with Moderna, to test the safety and immune responses of two mRNA vaccines. The HIV vaccines rely on the same mRNA technology found in the FDA-approved COVID-19 vaccines.